PHOENIX BIOTECH ACQUISITION CORP.

Merged

CIK: 1870404•Ticker: PBAX

Successfully merged with CERo Therapeutics • Now trading as

SPAC Overview

$155M

IPO Size

Completed

Current Status

2021

IPO Year

Timeline Progress

Investment Focus

Healthcare, Life Sciences

SPAC Team

Sponsors

Phoenix Biotech Sponsor

Leadership

Chief Executive Officer and Director

Chief Financial Officer

Brian G. Atwood

Kathleen LaPorte

Underwriters

Cantor Fitzgerald

Key Information

IPO Date

October 7, 2021

Completion Date

February 12, 2024

Merger Target

CERo Therapeutics

SPAC Ticker

PBAXU

External Resources

View Detailed Analysis